Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

David Richard Ziehr, M.D.

Concepts (133)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Respiration, Artificial3202127270.650 Why?
Coronavirus Infections3202031110.610 Why?
Pneumonia, Viral3202032330.610 Why?
Pulmonary Gas Exchange120203890.610 Why?
Respiratory Mechanics120207190.520 Why?
Prostatic Neoplasms152015110940.510 Why?
Pandemics3202087250.390 Why?
Respiratory Insufficiency1202012410.370 Why?
Physical Phenomena12010480.350 Why?
Ribosomes120104950.270 Why?
Antineoplastic Agents, Hormonal1201415350.260 Why?
Income1201418740.250 Why?
Androgen Antagonists1201414110.250 Why?
Molecular Chaperones120107600.250 Why?
SEER Program7201514430.200 Why?
Healthcare Disparities5201434070.190 Why?
Nitric Oxide Synthase Type III120247070.190 Why?
Coronary Disease1201459190.170 Why?
Exercise Tolerance120248410.160 Why?
Prone Position120202020.160 Why?
Prostatectomy3201517860.150 Why?
Renal Replacement Therapy120202820.150 Why?
Proto-Oncogene Proteins c-myc120239980.140 Why?
Patient Positioning120203300.140 Why?
Administration, Inhalation1202011540.140 Why?
Brachytherapy2201512180.140 Why?
Reference Standards1202010110.130 Why?
Vasoconstrictor Agents120206530.130 Why?
Lactic Acid1202111370.130 Why?
Fluid Therapy120205870.130 Why?
Vasodilator Agents120209880.130 Why?
Positive-Pressure Respiration120207120.120 Why?
Renal Insufficiency120208100.110 Why?
Goserelin120141260.110 Why?
Vascular Endothelial Growth Factor Receptor-2120165480.110 Why?
Anilides120164130.110 Why?
Leuprolide120143100.100 Why?
Insurance Coverage2201419450.100 Why?
Proto-Oncogene Proteins c-met120165620.100 Why?
Intubation, Intratracheal1202013590.100 Why?
Health Status Disparities2201418780.100 Why?
Organs at Risk120143520.100 Why?
Intensive Care Units2202137980.090 Why?
Prostate-Specific Antigen3201524630.090 Why?
Hydroxylamine12010170.090 Why?
Puromycin12010410.090 Why?
Sodium Hydroxide12010370.090 Why?
Ultracentrifugation120101550.090 Why?
Fluorescence Polarization120101400.080 Why?
Lung Diseases1202019410.080 Why?
Edetic Acid120102740.080 Why?
Ribonuclease, Pancreatic120101120.080 Why?
Diabetes Mellitus2202058890.080 Why?
Rectum120148960.080 Why?
Middle Aged1720242230830.080 Why?
Extracorporeal Membrane Oxygenation1202014800.080 Why?
Aged1620211712190.080 Why?
Metformin120159030.070 Why?
Adenocarcinoma2201563630.070 Why?
Salvage Therapy1201412730.070 Why?
Sepsis1202126030.070 Why?
Hospital Mortality1202153400.070 Why?
Aged, 80 and over62020595150.070 Why?
Neoplasms, Second Primary1201510560.070 Why?
Prostate1201517580.070 Why?
Geriatric Assessment1201414220.070 Why?
Protein Folding120108680.070 Why?
Male1920213639350.060 Why?
Humans2420247661170.060 Why?
Comorbidity12020105790.060 Why?
Cohort Studies22020416840.060 Why?
Pyridines1201628890.060 Why?
Risk Factors92021748570.060 Why?
Severity of Illness Index12021158820.050 Why?
Smoking1202090820.050 Why?
Escherichia coli Proteins1201010560.050 Why?
Procollagen-Proline Dioxygenase12023810.050 Why?
Body Mass Index12021130460.050 Why?
United States92021729200.050 Why?
Protein Biosynthesis1201020910.050 Why?
Retrospective Studies62021815650.050 Why?
Insurance, Health1201425200.050 Why?
Cell Hypoxia120236560.040 Why?
Hypertension1202086160.040 Why?
Signal Transduction12023236050.040 Why?
Mutation12024302090.040 Why?
Logistic Models12014132730.040 Why?
Hypoxia-Inducible Factor 1, alpha Subunit120236200.040 Why?
Obesity12021130850.040 Why?
Critical Illness2202127490.040 Why?
Adult720242231390.030 Why?
Socioeconomic Factors3201578430.030 Why?
Vascular Endothelial Growth Factor D12016610.030 Why?
Risk Assessment22015242760.030 Why?
Young Adult22020598680.030 Why?
Neoplasm Recurrence, Local1201493780.030 Why?
Massachusetts2202188820.030 Why?
Europe1202134300.030 Why?
Androgen Receptor Antagonists120151230.030 Why?
Survival Rate22021128270.030 Why?
Patient Protection and Affordable Care Act2201411880.030 Why?
Age Factors32015183860.030 Why?
Minority Health12014790.030 Why?
Diagnosis-Related Groups120154450.030 Why?
Marital Status120154260.030 Why?
Risk2201595990.030 Why?
Female620243962330.030 Why?
Postoperative Complications12014158080.020 Why?
Incidence32015215130.020 Why?
Epidemiologic Methods1201513250.020 Why?
Biopsy, Needle1201516130.020 Why?
Age of Onset1201533440.020 Why?
Magnetic Resonance Imaging12015365480.020 Why?
Radiotherapy Dosage1201428630.020 Why?
Disease-Free Survival1201668400.020 Why?
Kaplan-Meier Estimate1201665060.020 Why?
Neoplasm Metastasis1201648870.020 Why?
Neoplasms12014223440.020 Why?
Molecular Targeted Therapy1201628240.020 Why?
Lung12023100630.010 Why?
Population Surveillance1201425960.010 Why?
Feasibility Studies1201453000.010 Why?
Follow-Up Studies22015392430.010 Why?
Mortality1201429110.010 Why?
Survival Analysis12014100870.010 Why?
Hospitalization12021108110.010 Why?
Prognosis12021299120.010 Why?
Neoplasm Staging12015112000.010 Why?
Protein Kinase Inhibitors1201656950.010 Why?
Databases, Factual1201580620.010 Why?
Predictive Value of Tests12015154030.010 Why?
Quality of Life12014134680.010 Why?
Treatment Outcome12014652190.000 Why?
Ziehr's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (133)
Explore
_
Co-Authors (55)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2025 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.